HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 38,900
-1,200 (-2.99%)
At close: Aug 24, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 280.44 billion as of August 24, 2026. Its market cap has increased by 111.48% in one year.
Market Cap
280.44B
Enterprise Value
287.68B
Revenue
14.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
38,900.00
ChartMarket Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 280.44B, an increase of 145.61%. That is a compound annual growth rate of 64.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 280.44B | -14.37% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 618.80B |
| ImmuneOncia Therapeutics | 268.99B |
| Vivozon Pharmaceutical | 190.72B |
| NOVAREX | 185.44B |
| DAE HWA Pharmaceutical | 178.32B |
| Cosmax Nbt | 165.67B |
| CellBion | 165.06B |
| GC WellBeing | 151.01B |